Rudiger, A., Breitenstein, A., Arrigo, M., Salzberg, S. P., & Bettex, D. (2014). Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation.
Citação norma ChicagoRudiger, Alain, Alexander Breitenstein, Mattia Arrigo, Sacha P. Salzberg, and Dominique Bettex. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
MLA引文Rudiger, Alain, et al. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
警告:這些引文格式不一定是100%准確.